ClinicalTrials.gov
public full text
Public Domain
Airborne Ultrafine and Fine Particulate Matter: A Cause for Endothelial Dysfunction in Man?
The purpose of this study is to examine biological pathways of altered blood vessel function resulting from breathing airborne particulate. Blood artery function in healthy men will be measured after particulate exposure either on placebo or on an asthma medication that stops production of an inflammatory biological agent. Lung and blood profiles will be obtained before and after exposure to exhaust fumes. We believe that the inflammatory agent produced by the lungs from breathing these particles causes abnormal artery function.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Particulate matter in necropsy activities: experience from a health operators’ exposure monitoring campaign#308466
- Ultrafine Airborne Particle Deposition and Clearance in an Avian Lung under Ecologically Relevant Conditions#784589
- Ambient particulate matter pollution and stroke burden.#928196
- Bedside Air Quality in ICU and Clinical Outcome#859403
- Estimating the number of cardio-pulmonary events potentially averted by fine particulate matter air quality index activity guidelines#20019
Record · ID 891651
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive